Background: Evidence to date shows that mast cells play a critical role in immune defenses against infectious agents, but there have no reports about involvement of these cells in eliminating periodontopathogens. In this study, the phagocytic ability of mast cells against A. actinomycetemcomitans in comparison with macrophages was evaluated.
Periodontal biofilm hosts a wide diversity of potentially harmful bacterial species. Aggregatibacter actinomycetemcomitans has been described as member of the indigenous oral microbiota in many healthy individuals but is also largely involved in the pathology of periodontitis, 1, 2 the major cause of tooth loss in the world, 3 and various non-oral infections. 4, 5 A. actinomycetemcomitans is an oral Gram-negative bacterium and has shown the ability to invade periodontal tissues, establishing an infection. 6 Several studies have demonstrated that the evolution of biofilm-associated periodontal diseases is influenced by the host's inflammatory and immune responses against pathogens resulting in the destruction of soft and mineralized periodontal tissues, and involves the participation of different immune cells and their chemical mediators. [7] [8] [9] [10] [11] Currently, mast cells (MCs) have been associated with inflammatory periodontal diseases through release of pro-inflammatory and immunoregulatory cytokines, which activate other immune cells, such as neutrophils and lymphocytes, thus contributing to the development and amplification of the host's defense response. 12, 13 MCs are tissue-dwelling granule-containing immune cells that play a pivotal role in inflammatory and other processes such as the allergic immune response. 14, 15 MCs are commonly found in tissues that interface with the external environment such as the skin and mucosa of the respiratory and gastrointestinal tracts. 16 Because these sites are also common portals of infection, MCs are likely to be among the first inflammatory cells to interact with invading pathogens. 17 Studies have shown that MCs have the capacity to modulate the host's innate immune response against bacteria by their ability to phagocytose and kill bacteria, to process and present bacterial antigens to T cells, and to recruit phagocytic help through the release of physiological amounts of pro-inflammatory mediators. [18] [19] [20] [21] Moreover, MCs display a phagocytosis-independent antimicrobial activity against extracellular bacteria, producing extracellular traps and antimicrobial compounds. 17, 22, 23 Although phagocytic and microbicidal activity has been described in MCs against bacteria, the involvement of these cells in the elimination of periodontopathogens, via phagocytosis remains unclear. Since A. actinomycetemcomitans is one of the major periodontal pathogens, it is important to obtain more knowledge about the protective role of MCs against this microorganism. In this study, the phagocytic ability of mast cells against A. actinomycetemcomitans was determined and compared with the phagocytic capacity of macrophages.
MATERIALS AND METHODS

Isolation and Expansion of Bone Marrow-Derived Mast Cells
Primary mast cell lines were derived from femoral bone marrow of male C57BL/6 mice, 4 to 6-week-old. These animals were bred and maintained in the central animal facility of the Bauru School of Dentistry, University of Sao Paulo, Bauru, SP, Brazil. The experimental protocol was approved by the local Institutional Committee for Animal Care and Use (#028/2010). Mouse femoral bone marrow was removed by washing the medullary cavity with RPMI medium || supplemented with 10% heat-inactivated fetal bovine serum (FBS) || , 100 U/mL penicillin || , 100 µg/mL streptomycin || , 0.05 mM β-mercaptoethanol ¶ , and 36 µM sodium bicarbonate # . Bone marrow cells were dissociated by aspiration with a Pasteur pipette and the cells were then rinsed twice by centrifugation (400 xg for 10 minutes) in RPMI medium. Cells were counted and the viability was assessed by Trypan blue in a hemocytometer. After this, cells were cultured, 0.5 x 10 6 cells/mL, in RPMI supplemented with 100 ng/mL recombinant stem cell factor (SCF) ** and 20 ng/mL recombinant interleukin-3 (IL-3) ** , in a humidified atmosphere containing 5% CO 2 at 37°C. 24 By the end of 2-3 weeks, a nonadherent population of large granular cells was observed. Over the course of 21 days the bone marrow cells differentiated to mast cells (bone marrow-derived mast cells -BMMC).
By staining with toluidine blue, the isolated cells were shown to be homogeneous with typical granular appearance. Moreover, to further confirm their differentiation into mast cells, the cells were immunostained with antibodies against specific surface molecules of murine mast cells: antimouse CD117 (c-kit receptor) conjugated PE-Cy5 † † , anti-mouse Fc epsilon receptor (FcεRI) (highaffinity receptor for immunoglobulin E) conjugated PE † † and anti-AA4 conjugated to FITC (gangliosides derived from GD1b, present only on the surface of rodent mast cells). [24] [25] [26] After this, cells were analyzed by flow cytometry ‡ ‡ , according to parameters of size (FSC), granularity (SSC) and fluorescence intensity. Thus, the homogeneity of this cell population also was determined by flow cytometric analysis, revealing a BMMC purity > 98%.
Bacterial Growth
Previous studies conducted by Malaviya et al. 18 demonstrated that different bacterial strains including Escherichia coli bind avidly to mouse mast cells. This bacteria/mast cell interaction causes phagocytosis and bacterial killing. Therefore, to ensure that the BMMC were able to cause phagocytosis, the same assay was performed with E. coli as control.
The enteroinvasive E. coli 0:124 (EIEC) were initially grown on BHI agar § § , and incubated at 37°C for 24 hours. A. actinomycetemcomitans ATCC 29523 was grown on TSA plus 0.6% yeast extract |||| and the plates were incubated in 10% CO 2 at 37°C for 5 days. The bacterial concentration of A. actinomycetemcomitans was standardized at 1x10 9 CFU/mL and E. coli at 1x10 7 CFU/mL by spectrophotometer ¶ ¶ (A 660 nm ).
Phagocytosis Assay
This phagocytic assay was performed following the protocols of previous studies, 17, 18, 22, 27 and it was adjusted in accordance with the conditions of our laboratory. Initially, bacteria were opsonized via complement with a pool of human serum under shaking at 37°C for 30 minutes, and non-opsonized bacteria were used as control. BMMC were washed twice with RPMI-1640 medium without antibiotics and incubated with A. actinomycetemcomitans at 1:5, 1:10 and 1:25 ratios of cell:bacteria or with E. coli at 1:10, for 1 hour at 37°C under gentle agitation. Then, cells were centrifuged at 218 xg, at 24°C, for 10 minutes and the pellet resuspended in 200 mL of RPMI-1640 medium. The cell suspensions were transferred to 24-well plates, containing sterile spherical glass coverslip (13 mm in diameter), and pre-treated with tissue adhesive ## allowing cell adhesion. The wells were washed with PBS to remove the extracellular bacteria. The coverslips with cells attached were fixed with 2% paraformaldehyde (PFA) in PBS for 20 minutes and washed again with PBS. Then they were stained with 0.05 mg/mL acridine orange *** for 15 minutes in a dark room. After this, coverslips were carefully removed and placed on glass slides with mounting medium † † † . The slides were qualitatively evaluated by a confocal laser scanning electron microscopy ‡ ‡ ‡ , which initially allowed entrapped bacteria to be differentiated from bacteria only bound to the mast cell surface molecules. Thereafter quantitative analysis was performed at 100x magnification, by counting the MCs with internalized bacteria, in 20 randomly captured fields § § § . Phagocytosis was assessed by considering the number of internalized bacteria per cell (≤ 5 and > 5). Cells with absence of internalized bacteria also were counted. The results were expressed in percentages, and were obtained from the average of three independent experiments, considering the total number of cells counted per coverslip (20 fields) in each experiment.
Simultaneously to BMMC, phagocytosis assays against A. actinomycetemcomitans were performed by using mouse peritoneal macrophages (MPM), allowing the phagocytic capacity of cell types, mast cells and macrophages, to be compared. MPM were obtained according to the methodology of Murciano et al. (2008) . 28 
Statistical Analysis
The results are expressed as the mean ± SD (standard deviation) from three independent experiments (1 mouse in each experiment for testing mast cells and 4 mice for macrophages). Data were analyzed by using an analysis of variance (two-way ANOVA) and Tukey's test, followed by Student's-t test |||||| . Values of p<0.05 were considered statistically significant.
RESULTS
BMMC Act as Phagocytes Against A. Actinomycetemcomitans, Especially in the Absence of Serum Opsonization.
In this study, by using a ratio of 1:25 (BMMC:bacteria), the percentage of BMMC with opsonized A. actinomycetemcomitans was higher when compared with BMMC without bacteria (p=0.011). Most of the cells displayed more than five internalized bacteria.
Interestingly, in the absence of opsonization, BMMC presenting ingested bacteria were more numerous than cells without bacteria in all BMMC-bacterial ratios used. In addition, a higher percentage of BMMC with non-opsonized bacteria was detected in comparison with BMMC with bacteria opsonized, in the ratios 1:5 and 1:10 (p=0.02 and p=0.004, respectively).
Considering BMMC with more than five internalized bacteria, the cells incubated with nonopsonized bacteria were more numerous than the BMMC with opsonized bacteria only in the ratio of 1:10 (p=0.0008) (Figures 1 and 2 ).
In the Absence of Serum Opsonization, BMMC Displayed More Ingested A. Actinomycetemcomitans than MPM.
When comparing the phagocytic activity of BMMC with professional phagocytes (MPM) against opsonized A. actinomycetemcomitans, the percentage of MPM with up to five internalized bacteria was higher than BMMC in 1:5 and 1:25 ratios (p=0.03 and p=0.02, respectively). However, the percentage of BMMC that had more than five internalized bacteria was higher than that of MPM, in the ratio of 1:5 (p= 0.04).
In the absence of opsonization, MPM without internalized bacteria were more numerous than BMMC, in all the ratios evaluated. Moreover, there were also higher percentages of BMMC with more than five internalized bacteria than those observed for MPM in all ratios (Figure 3 ). When comparing the two cell types with opsonized E. coli (1:10), the percentage of MPM with more than five internalized bacteria was higher than BMMC. Moreover, the percentage of MPM without opsonized bacteria was lower than BMMC. In the absence of opsonization, the opposite was observed since the percentage of BMMC with more than five internalized bacteria was higher in comparison with MPM.
Similar to the phagocytic assays with A. actinomycetemcomitans, percentages of BMMC without internalized E. coli ranged according to the presence or absence of previous bacterial opsonization. BMMC without opsonized E. coli were more numerous than BMMC with absence of non-opsonized E. coli. Conversely, MPM without non-opsonized E. coli displayed higher percentages compared with MPM without internalization of opsonized bacteria, suggesting that serum opsonization amplified bacterial internalization by MPM but not by BMMC ( Figure 5 ) as observed for A. actinomycetemcomitans.
DISCUSSION
The contribution of MCs to the host defense has become increasingly recognized in recent years. It is known that MCs have the ability to recognize and phagocytose infectious agents through specific receptors present on their surfaces. [29] [30] [31] From in vitro assays, we are able to demonstrate for the first time, the participation of murine MCs as phagocytes against the periodontopathogen A. actinomycetemcomitans, especially in the absence of opsonization with human serum. Considering that the Fc portion of immunoglobulin is variable between species, 32 the bacterial opsonization by human serum supplied only complement system proteins for opsonin-dependent phagocytosis by murine cells.
In the present study, opsonized A. actinomycetemcomitans with complement were not phagocytosed by BMMC as efficiently as it was without opsonization. Probably, the recognition of A. actinomycetemcomitans by murine BMMC, when independent of complement receptor, seems to have remarkable implications, because percentages of BMMC with non-opsonized bacteria were higher than BMMC without these bacteria or than BMMC with opsonized bacteria, after comparisons in the same ratios. In addition, high percentages of BMMC had more than five internalized A. actinomycetemcomitans, especially in the absence of opsonization. Similar results were observed with BMMC challenged with E. coli by comparing the presence or absence of opsonization.
It is now known that the MCs contain numerous surface receptors, including those that promote recognition and bacterial binding. MCs exhibit two basic mechanisms of microbial recognition: opsonin-dependent (via Fc and C3 receptors) and opsonin-independent (via integrins, CD48 molecule and Toll-like receptors-TLR). [33] [34] [35] [36] In agreement with our results, the recognition and ingestion of A. actinomycetemcomitans by murine BMMC involve either opsonin-dependent or opsonin-independent receptors, in agreement with Malaviya et al. 35 who demonstrated the recognition of E. coli by MCs.
Since A. actinomycetemcomitans produces diverse bacterial products such as lipopolysaccharide (LPS) and peptidoglycan (PGN) mediated by TLR2 and TLR4 receptors, 31, [37] [38] [39] the TLR pathway may represent another route of recognition and internalization of this periodontopathogen by the MCs studied here, since MCs express TLR1, 2, 3, 4, 6 and 9. 36, 40, 41 However, further studies are needed to unravel which extracellular receptors on these cells are involved more frequently and efficiently in the recognition and ingestion of A. actinomycetemcomitans.
In the present study, unlike BMMC, macrophages with opsonized bacteria were more frequent than macrophages with non-opsonized bacteria, suggesting that complement system proteins resulted in more efficient internalization by these cells than BMMC, for both A. actinomycetemcomitans and E. coli. Furthermore, in a ratio of 1:10, BMMC with non-opsonized A. actinomycetemcomitans were more numerous than macrophages with opsonized A. actinomycetemcomitans, suggesting that BMMC phagocytosed more efficiently non-opsonized periodontopathogens than macrophages against opsonized bacteria with complement. However, we cannot rule out the possibility that these opsonized bacteria were killed by macrophages after internalization, supporting some findings, [42] [43] [44] which observed phagocytosis by macrophages with bacterial death in an opsonin-rich environment. After comparison of phagocytosis by both cell types, our results showed that the BMMC could be considered professional phagocytes against A. actinomycetemcomitans, in the same way as macrophages are, irrespective of the bacterial killing. It is important to emphasize that the bacterial phagocytosis by both cell populations occurred in a bacterial load-independent manner.
Based on the methodology used, it was not possible to verify the viability of internalized bacteria. Malaviya et al. 18 demonstrated that murine MCs were able to phagocytose and kill Gramnegative bacteria in a medium containing serum components, by means of non-oxidative and oxidative mechanisms. However, several bacteria can affect this phagocytic ability of MCs to their advantage when in opsonin-poor microenvironments, 45 thus inducing the cell to become an intracellular environment in which bacteria could proliferate and contribute to bacterial spreading. Under these conditions, MCs would then serve as reservoirs of viable bacteria, resulting in harmful effects to the host. 46 In fact, our results revealed high percentages of MCs with more than five internalized A. actinomycetemcomitans, mainly in the absence of opsonization through complement. Accordingly, C3-deficient mice presented functional impairment of MCs with delayed elimination of bacteria and reduction in their degranulation and production of TNF-α, suggesting that products of the complement system are essential for the activation and microbicidal activity of MCs after bacterial challenge. 47 Moreover, E. coli phagocytosis by MCs through CD48 molecule (GPIanchored glycosylphosphatidylinositol) promoted bacterial death more efficiently than through CR3. 35 When MCs interact with opsonized bacteria, and perform their phagocytic and microbicidal functions, they simultaneously release considerable amounts of pro-inflammatory mediators, thereby leading to the migration of more inflammatory cells at the infectious focus. [48] [49] [50] When there is excessive release of mediators, it can result in exacerbation of the inflammatory process, causing serious cytotoxic effects on tissues. However, several internalized bacterial pathogens express toxins that can inhibit the release of chemical mediators by MCs. 45 Thus, we are tempted to think that the phagocytic response of MCs against A. actinomycetemcomitans can be ambiguous in biofilm-associated periodontal diseases either protecting the individual by phagocytosis and bacterial killing or leading to further destruction and progression of the disease by exacerbated release of mediators. Moreover, MCs could be an intracellular refuge for periodontopathogens. With regard to these considerations, there continue to be conflicting views on whether phagocytosis by mast cells plays a protective or harmful role in relation to clinical progression of periodontal disease. Although there is broad scientific knowledge about the pathogenesis of periodontal diseases, further studies are needed for a better understanding of the biological events involved in this pathology, especially those related to mast cells.
Finally, this early in vitro investigation proved the phagocytic capacity of MCs against A. actinomycetemcomitans. Although this is an in vitro study and only confocal scanning electron microscopy was used as method to analyze phagocytosis, the results obtained here lead to the hypothesis of a possible role of mast cells as professional phagocytes in a manner similar to that of macrophages. In a further study, we intend to investigate the microbicidal activity of MCs against internalized A. actinomycetemcomitans, whether opsonized or not, thus contributing to a better understanding of the real importance of bacterial phagocytosis by MCs in inflammatory PD. In the context of infectious diseases, especially PD, it is likely that this will not only expand the scope of our knowledge of the role of MCs in innate immunity with regard to these diseases, but may provide new therapeutic targets to control the inflammatory response in gingival and periodontal tissues against the periodontopathogens. 
